1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Vivaldi Biosciences Inc. - Product Pipeline Review - 2015

Vivaldi Biosciences Inc. - Product Pipeline Review - 2015

  • August 2015
  • -
  • Global Markets Direct
  • -
  • 20 pages

Vivaldi Biosciences Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Vivaldi Biosciences Inc. - Product Pipeline Review - 2015’, provides an overview of the Vivaldi Biosciences Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vivaldi Biosciences Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Vivaldi Biosciences Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Vivaldi Biosciences Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Vivaldi Biosciences Inc.’s pipeline products

Reasons to buy

- Evaluate Vivaldi Biosciences Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Vivaldi Biosciences Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Vivaldi Biosciences Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Vivaldi Biosciences Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vivaldi Biosciences Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Vivaldi Biosciences Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Vivaldi Biosciences Inc. - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Vivaldi Biosciences Inc. Snapshot 4
Vivaldi Biosciences Inc. Overview 4
Key Information 4
Key Facts 4
Vivaldi Biosciences Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Vivaldi Biosciences Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Vivaldi Biosciences Inc. - Pipeline Products Glance 9
Vivaldi Biosciences Inc. - Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Vivaldi Biosciences Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Vivaldi Biosciences Inc. - Drug Profiles 11
GHB-16L2 Vaccine 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
influenza [strain A/H7N9] vaccine 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
VB126 LAIV 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Vivaldi Biosciences Inc. - Pipeline Analysis 14
Vivaldi Biosciences Inc. - Pipeline Products by Route of Administration 14
Vivaldi Biosciences Inc. - Pipeline Products by Molecule Type 15
Vivaldi Biosciences Inc. - Recent Pipeline Updates 16
Vivaldi Biosciences Inc. - Dormant Projects 17
Vivaldi Biosciences Inc. - Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 19
Disclaimer 20

List of Tables
Vivaldi Biosciences Inc., Key Information 4
Vivaldi Biosciences Inc., Key Facts 4
Vivaldi Biosciences Inc. - Pipeline by Indication, 2015 6
Vivaldi Biosciences Inc. - Pipeline by Stage of Development, 2015 7
Vivaldi Biosciences Inc. - Monotherapy Products in Pipeline, 2015 8
Vivaldi Biosciences Inc. - Phase I, 2015 9
Vivaldi Biosciences Inc. - Preclinical, 2015 10
Vivaldi Biosciences Inc. - Pipeline by Route of Administration, 2015 14
Vivaldi Biosciences Inc. - Pipeline by Molecule Type, 2015 15
Vivaldi Biosciences Inc. - Recent Pipeline Updates, 2015 16
Vivaldi Biosciences Inc. - Dormant Developmental Projects,2015 17

List of Figures
Vivaldi Biosciences Inc. - Pipeline by Top 10 Indication, 2015 6
Vivaldi Biosciences Inc. - Pipeline by Stage of Development, 2015 7
Vivaldi Biosciences Inc. - Monotherapy Products in Pipeline, 2015 8
Vivaldi Biosciences Inc. - Pipeline by Top 10 Route of Administration, 2015 14
Vivaldi Biosciences Inc. - Pipeline by Top 10 Molecule Type, 2015 15

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016’, provides an overview ...

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2016

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Haemophilus influenzae Type B Infections ...

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016’, provides an overview ...


Download Unlimited Documents from Trusted Public Sources

GSK - Company Report, November 2016

  • November 2016
    90 pages
  • Vaccine  

    Infectious Dise...  

  • World  

    United Kingdom  

    Europe  

View report >

GSK - Company Report, November 2016

  • November 2016
    90 pages
  • Vaccine  

    Infectious Dise...  

  • World  

    United Kingdom  

    Europe  

View report >

GSK - Company Report, November 2016

  • November 2016
    90 pages
  • Vaccine  

    Infectious Dise...  

  • World  

    United Kingdom  

    Europe  

View report >

Related Market Segments :

Influenza
Vaccine

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.